Compare · COR vs WGRX
COR vs WGRX
Side-by-side comparison of Cencora Inc. (COR) and Wellgistics Health Inc. (WGRX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both COR and WGRX operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- COR is the larger of the two at $60.29B, about 6470.4x WGRX ($9.3M).
- Over the past year, COR is up 6.7% and WGRX is down 92.2% - COR leads by 98.9 points.
- WGRX has been more active in the news (7 items in the past 4 weeks vs 5 for COR).
- COR has more recent analyst coverage (25 ratings vs 0 for WGRX).
- Company
- Cencora Inc.
- Wellgistics Health Inc.
- Price
- $309.71+1.54%
- $3.52+27.72%
- Market cap
- $60.29B
- $9.3M
- 1M return
- +8.87%
- +2.47%
- 1Y return
- +6.71%
- -92.23%
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NYSE
- NASDAQ
- IPO
- 2025
- News (4w)
- 5
- 7
- Recent ratings
- 25
- 0
Cencora Inc.
CoreSite Realty Corporation (NYSE:COR) delivers secure, reliable, high-performance data center, cloud access and interconnection solutions to a growing customer ecosystem across eight key North American markets. More than 1,375 of the world's leading enterprises, network operators, cloud providers, and supporting service providers choose CoreSite to connect, protect and optimize their performance-sensitive data, applications and computing workloads. Our scalable, flexible solutions and 460+ dedicated employees consistently deliver unmatched data center options  all of which leads to a best-in-class customer experience and lasting relationships.
Latest COR
- Executive Vice President Battaglia Silvana was granted 58 shares, increasing direct ownership by 0.25% to 23,624 units (SEC Form 4)
- Executive Vice President Campbell Elizabeth S was granted 50 shares, increasing direct ownership by 0.16% to 30,756 units (SEC Form 4)
- Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release
- SEC Form 4 filed by Chief Financial Officer Boratto Eva C
- New insider Boratto Eva C claimed ownership of 3 shares (SEC Form 3)
- Director Tyler Lauren M bought $148,626 worth of shares (550 units at $270.23), increasing direct ownership by 14% to 4,359 units (SEC Form 4)
- Director Durcan Dermot Mark bought $1,096,760 worth of shares (4,000 units at $274.19), increasing direct ownership by 14% to 31,767 units (SEC Form 4)
- SEC Form 11-K filed by Cencora Inc.
- Cencora Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Cencora Announces Samantha Hammock as Chief Human Resources Officer
Latest WGRX
- DataMEDS AI Officially Begins Trading Under Stock Symbol 'MEDS' on the NASDAQ Capital Markets
- Wellgistics Health Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
- WELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC.
- Wellgistics Health Announces Updated Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders
- Rubenstein Public Relations Named Agency of Record for Wellgistics Health, Inc.
- Wellgistics Health Appoints Brett Thompson as Chief Technology Officer
- Wellgistics Health Executive Chairman and President Exercise Warrants
- DataMeds AI, Inc. Selected as Proposed New Name for Wellgistics Health, Inc.
- Director Ajjarapu Surendra K exercised 100,000 in-the-money shares at a strike of $0.01, increasing direct ownership by 63% to 257,645 units (SEC Form 4)
- Chief Executive Officer Patel Prashant exercised 100,000 in-the-money shares at a strike of $0.01, increasing direct ownership by 55% to 282,365 units (SEC Form 4)